AP Medical Writer Some people who took a new schizophrenia drug for one year improved with only a few side effects, but many dropped out of the research. That’s according to company-sponsored studies reported Thursday. Schizophrenia is a severe mental illness that can cause people to hear voices, feel paranoid and withdraw from others. Bristol Myers Squibb’s Cobenfy was approved by the U.S. Food and Drug Administration in September. There’s been great hope among doctors because the drug acts in the brain differently than other schizophrenia medicines. The latest results presented at a medical meeting in Boston come from two yearlong studies. The post A promising schizophrenia drug showed
Hence then, the article about a promising schizophrenia drug showed mixed results what does that mean for patients was published today ( ) and is available onNews channel ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( A promising schizophrenia drug showed mixed results. What does that mean for patients? )